%0 Journal Article
%T Case report: When measured free T4 and free T3 may be misleading. Interference with free thyroid hormones measurements on Roche  and Siemens  platforms
%A Lewandowski Krzysztof C
%A D£¿browska Katarzyna
%A Lewi¨½ski Andrzej
%J Thyroid Research
%D 2012
%I BioMed Central
%R 10.1186/1756-6614-5-11
%X A 59-year old female patient presented with apathy and 6 kg weight gain. Investigations revealed severe primary hypothyroidism (TSH>100 ¦ÌIU/ml). L-thyroxine (L-T4) was started and titrated up to 75 ¦Ìg, once daily, with clinical improvement. Other investigations revealed very high titres of anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) antibodies. After three months, there was a fall in TSH to 12.74 ¦ÌIU/ml, however, with unexpectedly high free T4 (FT4) - 6.8 ng/ml and free T3 (FT3) - 6.7 pg/ml concentrations [reference range (rr): 0.8-1.9 ng/ml and 1.5-4.1 pg/ml (Siemens ), respectively]. At this stage L-T4 was stopped, and this was followed by a rapid increase in TSH (to 77.76 ¦ÌIU/ml) and some decrease in FT4 and FT3, however FT4 concentration remained elevated (2.1 ng/ml). Following this, L-T4 was restarted. On admission to our Department, she was clinically euthyroid on L-T4, 88 ¦Ìg, once daily. Investigations on Roche  platform confirmed mildly elevated TSH - 5.14 (rr: 0.27-4.2 ¦ÌIU/ml) with high FT4 [4.59 (rr: 0.93-1.7 ng/ml)] and FT3 [4.98 (rr: 2.6-4.4 pg/ml)] concentrations. Other tests revealed hypoechogenic ultrasound pattern typical for Hashimoto thyroiditis. There was no discrepancy in calculated TSH value following TSH dilution (101% recovery). Concentrations of FT4 and FT3 were assessed on the day of discontinuation of L-T4 and after four days by the means of Abbott  Architect I 1000SR platform. These revealed FT4 and FT3 concentrations within the reference range [e.g., FT4 - 1.08 ng/ml (rr: 0.7-1.48)] vs 4.59 ng/ml (rr: 0.93-1.7, Roche ), FT3 - 3.70 pg/ml (rr: 1.71-3.71) vs 4.98 (rr: 2.6-4.4, Roche )], confirming assay interference. Concentrations of ferritin and SHBG were normal. Conclusions Clinicians must be aware of possible assay interference, including the measurements of FT4 and FT3 in the differential diagnosis of abnormal results of thyroid function tests that do not fit the patient clinical presentation.
%K Free T4
%K Free T3
%K Assay interference
%U http://www.thyroidresearchjournal.com/content/5/1/11